Archive | September, 2011

Rally Rolls Over: Trading Range Intact-Biotech Outperforms in September

A 2.7+% rally faded today as European debt crisis  headlines put a damper on optimism. Many of the pundits were skeptical of the rally saying it was driven by short covering. Biotechs Outperforming This Month With all of this volatility you’d think we found a trend. But the three day rally has only brought the […]

Continue Reading 0

Nasty Day Reminds Us: The FED is Running Out of Juice

S&P Sells Off 2.94%-Caution Comes Back as Market is Down 4% in 3 Trading Days Something happened, but maybe we were just reminded that the economic picture is still grim and monetary policy has done what it can. Europe is still a time bomb with funding for Greece  not resolved and even Italy on the […]

Continue Reading 0

Healthcare Sector Gets Upgrade from Morgan Stanley

Biotechnology,Pharmaceuticals and Healthcare Providers Are Most Attractive After a five day rally led by chips, tech and industrials Morgan Stanley came out today calling the healthcare sector an overweight. Adam Parker, the US Equity Strategist published a report with the key themes and top picks by the US Healthcare Team. In a detailed 25 page […]

Continue Reading 0

European Rally Spills Over to US but Life Science Tools/DX Weak

A short term liquidity deal by the ECB to lend dollars to Euro-area banks has taken the heat off the sovereign debt crisis. For now.Many analysts however offer caution that the long term solvency issues have not been resolved. It does show that international central banks are working together. European markets were up 3% + […]

Continue Reading 0

Spontaneous Rally as Greece Bailout is Alive: Risk On

You can’t say we didn’t warn you that traders were tired of selling. Selling was exhausted by Monday as futures were down then turned positive by mid-day Monday. The roller coaster market tied to European chit chat is too amazing. Today the focus was on what Austria would do (they have not decided). But although […]

Continue Reading 0

Healthcare and Biotech for Relative Safety: ALXN, REGN, OPTR, SGEN

A Place to Hide from Volatility Today was not as bad as early futures and European markets would portend. The S&P cut its losses to 0.74% and the NASDAQ was down only 0.26%. But as we recommended last month the healthcare sector looks good for relative safety. Drug stocks that pay dividends and large cap […]

Continue Reading

European Debt esp Greece Drive Market Down 2.8%

Imminent Greek Default? Buyers on Hold for the Weekend The familiar pattern comes back to haunt US markets as an ECB official resigned sparking a downdraft within 1o minutes. Jurgen Stark, a German who sits on the Board of the European Central Bank is an opponent of the bank’s buying program. Over the past few […]

Continue Reading 0

Nice Market Turnaround Today: NASDAQ up 1%

We are at the Rodman And Renshaw Meeting today while the market ignored macro events and found buyers in the life sciences and tech sectors. We will offer some bottom fishing ideas this week in addition to stocks mentioned last week. The trade for any upswing is long qqq providing biotech, tech and internet weighting. […]

Continue Reading 1

Nice Market Turnaround Today: NASDAQ up 1%

We are at the Rodman And Renshaw Meeting today while the market ignored macro events and found buyers in the life sciences and tech sectors. We will offer some bottom fishing ideas this week in addition to stocks mentioned last week. The trade for any upswing is long qqq providing biotech, tech and internet weighting. […]

Continue Reading 0

European Debt esp Greece Drive Markets Down 2.8%

Imminent Greek Default? Buyers on Hold for the Weekend The familiar pattern comes back to haunt US markets as an ECB official resigned sparking a downdraft within 1o minutes. Jurgen Stark, a German who sits on the Board of the European Central Bank is an opponent of the bank’s buying program. Over the past few […]

Continue Reading 0